Transfer learning enables predictions in network biology.

Journal: Nature
PMID:

Abstract

Mapping gene networks requires large amounts of transcriptomic data to learn the connections between genes, which impedes discoveries in settings with limited data, including rare diseases and diseases affecting clinically inaccessible tissues. Recently, transfer learning has revolutionized fields such as natural language understanding and computer vision by leveraging deep learning models pretrained on large-scale general datasets that can then be fine-tuned towards a vast array of downstream tasks with limited task-specific data. Here, we developed a context-aware, attention-based deep learning model, Geneformer, pretrained on a large-scale corpus of about 30 million single-cell transcriptomes to enable context-specific predictions in settings with limited data in network biology. During pretraining, Geneformer gained a fundamental understanding of network dynamics, encoding network hierarchy in the attention weights of the model in a completely self-supervised manner. Fine-tuning towards a diverse panel of downstream tasks relevant to chromatin and network dynamics using limited task-specific data demonstrated that Geneformer consistently boosted predictive accuracy. Applied to disease modelling with limited patient data, Geneformer identified candidate therapeutic targets for cardiomyopathy. Overall, Geneformer represents a pretrained deep learning model from which fine-tuning towards a broad range of downstream applications can be pursued to accelerate discovery of key network regulators and candidate therapeutic targets.

Authors

  • Christina V Theodoris
    Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
  • Ling Xiao
    Cardiovascular Disease Initiative and Precision Cardiology Laboratory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Anant Chopra
    Precision Cardiology Laboratory, Bayer US LLC, Cambridge, MA, USA.
  • Mark D Chaffin
    Cardiovascular Disease Initiative, Broad Institute, Cambridge, MA, USA.
  • Zeina R Al Sayed
    Cardiovascular Disease Initiative and Precision Cardiology Laboratory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Matthew C Hill
    Cardiovascular Disease Initiative and Precision Cardiology Laboratory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Helene Mantineo
    Cardiovascular Disease Initiative and Precision Cardiology Laboratory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Elizabeth M Brydon
    Precision Cardiology Laboratory, Bayer US LLC, Cambridge, MA, USA.
  • Zexian Zeng
    Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • X Shirley Liu
    Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. Electronic address: xsliu@ds.dfci.harvard.edu.
  • Patrick T Ellinor
    Cardiovascular Disease Initiative, Broad Institute of Harvard and the Massachusetts Institute of Technology, Cambridge, Massachusetts.